FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Thank You

Your support powers research breakthroughs, access to care, and community connections that matter.

Thank you

Thank you for completing MDA’s online HIPAA training. We have received your signed Health Privacy and Security Policy form. 
 
We appreciate your continued commitment to help save and improve the lives of people with muscular dystrophy by volunteering with MDA.

Find MDA
in your Community